ABBV vs LLY
ABBV 与 LLY 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | ABBVAbbVie Inc. | LLYELI LILLY AND COMPANY |
|---|---|---|
| 市值 | $431.41B | $1.11T |
| 市盈率(TTM) | 69.0 | 39.5 |
| 市净率 | — | 32.72 |
| 市销率 | 7.0x | 17.0x |
| 股息率 | 2.70% | 0.49% |
| 营收 | $61.16B(TTM) | $79.67B(TTM) |
| 营收同比增长 | 8.6% | 44.7% |
| 净利润 | $6.31B(TTM) | $26.71B(TTM) |
| 净利同比增长 | -1.2% | 94.9% |
| 每股收益(稀释) | $3.54(TTM) | $29.79(TTM) |
| 息税前利润率 | 24.6% | 40.2% |
| 净资产收益率 | — | 60.9% |
| 投入资本回报率 | 18.6% | 26.3% |
| 一年总回报 | +25.9% | +84.5% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:ABBV vs LLY
| 指标 | ABBV | LLY |
|---|---|---|
| 期末价值 | $62.6K | $186.4K |
| 总回报 | +526.0% | +1763.7% |
| 年化收益 (CAGR) | +19.4% | +32.7% |
| 波动率 | 25.8% | 30.0% |
| 夏普比率 | 0.67 | 0.96 |
| 索提诺比率 | 0.93 | 1.50 |
| 最大回撤 | -45.1% | -34.5% |
基于 2600 个共同交易日,2016-04-06 → 2026-08-07 · 无风险利率 3.9%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)